cp wire

CP Wire Articles

Cidara Therapeutics Initiates Ph III Trial of Rezafungin for Treatment of Invasive Candida Infections
  • Rezafungin has fast track and Qualified Infectious Disease Product (QIDP) designations to rezafungin for for the prevention of invasive fungal infections in adults undergoing allogeneic bone... read more
Thu, 09/27/18 - 10:23 am
CytoSen Therapeutics Receives Favorable Response to Pre-IND Meeting Package for Phase 2 Study in Acute Myeloid Leukemia

CytoSen Therapeutics, a private biopharmaceutical company accelerating innovation in Natural Killer (NK) cell therapy, announced on 9/27/18 it has received a favorable response from the U.S. Food... read more

Thu, 09/27/18 - 09:57 am
Veracyte to Present Data Supporting Use of Their Non-Invasive Diagnostics for Lung Diseases
  • Percepta relies on cells taken during a normal bronchoscopy
  • Envisia uses patient samples that are obtained using transbronchial biopsy


Veracyte, Inc. (NASDAQ: VCYT)... read more

Thu, 09/27/18 - 09:36 am
ENT Focused Lyra Therapeutics Banks $29.5 Million Series B Round
  • LYR-210 has the potential to be the first approved drug product for CRS
  • The product can deliver relief for up to six months
  • In the United States, chronic rhinosinusitis has... read more
Wed, 09/26/18 - 09:49 am
AI Digital Pathology Company Closes $8.3 Million Series A Round

Proscia announced on 9/26/18 that it has closed an $8.3 million round of Series A financing from a group of East and West Coast venture capital firms. The funding was led by Boston-based Flybridge... read more

Wed, 09/26/18 - 09:29 am

Pages